Diets · Metabolic & Cardiometabolic
Does lowering cholesterol more cut heart risk more?
The claim, precisely: magnitude of LDL reduction correlates with cardiovascular disease
No — across trials the link is weak, but this doesn't mean cholesterol is harmless.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
At the trial level, the MAGNITUDE of LDL lowering is a weak predictor of the size of a statin's cardiovascular benefit (Byrne 2022; Liaigre 2025, R^2~0). Norwitz uses this to attack LDL. The honest nuance: this is about dose-response SURROGACY across heterogeneous trials - it does NOT overturn LDL CAUSALITY, which Mendelian randomization and per-mmol CTT analyses support. So: low confidence in the
The evidence (5)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Liaigre L, et al. 2025 · Eur Heart J Cardiovasc Pharmacother | meta-analysis | contradicts | low | Umbrella MA 20 RCTs/194,686: trial-level R^2 for LDL vs CV outcomes ~0-0.1 |
| Li 2021 · Eur J Clin Invest | meta-analysis | mixed | high | Umbrella review: many drug-outcome associations weak; anchors that magnitude-benefit links are often overstated |
| Byrne P, et al. 2022 · JAMA Intern Med | meta-analysis | contradicts | moderate | [FT-verified] Byrne2022: weak LDL-MI corr, R2=0 for mortality/stroke; benefit not strongly LDL-mediated at trial level |
| Byrne P, et al. 2022 · JAMA Intern Med | meta-analysis | contradicts | moderate | MA 21 RCTs: weak/inconsistent association between LDL-lowering magnitude and absolute outcome reductions |
| Liaigre L, et al. 2025 · Eur Heart J Cardiovasc Pharmacother | meta-analysis | contradicts | high | [FT-verified] Liaigre2025 umbrella 20RCTs/194k: trial-level R2 0-0.1 LDL (valid needs>=0.65); lit discrepant; individual surrogacy holds |
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.